blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2975051

EP2975051 - READILY ISOLATED BISPECIFIC ANTIBODIES WITH NATIVE IMMUNOGLOBULIN FORMAT [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  18.02.2022
Database last updated on 16.09.2024
FormerThe patent has been granted
Status updated on  12.03.2021
FormerGrant of patent is intended
Status updated on  02.11.2020
FormerExamination is in progress
Status updated on  10.08.2018
Most recent event   Tooltip18.02.2022No opposition filed within time limitpublished on 23.03.2022  [2022/12]
Applicant(s)For all designated states
Regeneron Pharmaceuticals, Inc.
777 Old Saw Mill River Road
Tarrytown, NY 10591 / US
[2021/15]
Former [2016/03]For all designated states
Regeneron Pharmaceuticals, Inc.
777 Old Saw Mill River Road
Tarrytown, NY 10591 / US
Inventor(s)01 / DAVIS, Samuel
332 West 88th Street
Apt. B2
New York, NY 10024 / US
02 / SMITH, Eric
310 Lexington Avenue
Apt. 4E
New York, NY 10016 / US
03 / MACDONALD, Douglas
260 West End Avenue
Apt. 10C
New York, NY 10023 / US
04 / OLSON, Kara Louise
30 Prospect Street
White Plains, NY 10605 / US
 [2016/08]
Former [2016/03]01 / DAVIS, Samuel
332 West 88th Street
Apt. B2
New York, NY 10024 / US
02 / SMITH, Eric
310 Lexington Avenue
Apt. 4E
New York, NY 10016 / US
03 / MACDONALD, Douglas
260 West End Avenue
Apt. 10C
New York, NY 10023 / US
04 / OLSON, Kara Louise
90 Bryant Avenue
4E-E
White Plains, NY 10605 / US
Representative(s)Hoffmann Eitle
Patent- und Rechtsanwälte PartmbB
Arabellastraße 30
81925 München / DE
[2021/15]
Former [2016/03]Power, David
J A Kemp
14 South Square
Gray's Inn
London WC1R 5JJ / GB
Application number, filing date15181155.125.06.2010
[2016/03]
Priority number, dateUS20090220687P26.06.2009         Original published format: US 220687 P
[2016/03]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2975051
Date:20.01.2016
Language:EN
[2016/03]
Type: B1 Patent specification 
No.:EP2975051
Date:14.04.2021
Language:EN
[2021/15]
Search report(s)(Supplementary) European search report - dispatched on:EP09.10.2015
ClassificationIPC:C07K16/06, C07K16/46, A61K39/00, C07K16/28, C07K16/24
[2016/03]
CPC:
C07K1/22 (EP,IL,US); C07K1/00 (RU); C07K16/06 (KR);
A61K39/395 (KR); C07K1/06 (RU); C07K1/08 (RU);
C07K1/088 (RU); C07K16/18 (RU); C07K16/247 (IL,US);
C07K16/248 (IL,US); C07K16/2809 (EP,IL,US); C07K16/2866 (EP,IL,US);
C07K16/2887 (EP,IL,US); C07K16/46 (KR); C07K16/461 (KR);
C07K16/468 (IL,KR,US); A61K2039/505 (EP,IL,US); C07K2317/21 (EP,IL,US);
C07K2317/31 (EP,IL,US); C07K2317/52 (EP,IL,US); C07K2317/526 (IL,US);
C07K2317/56 (EP,IL,US); C07K2317/76 (IL,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2016/35]
Former [2016/03]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  SM,  TR 
TitleGerman:LEICHT ZU ISOLIERENDE BISPEZIFISCHE ANTIKÖRPER MIT NATIVEM IMMUNGLOBULINFORMAT[2016/03]
English:READILY ISOLATED BISPECIFIC ANTIBODIES WITH NATIVE IMMUNOGLOBULIN FORMAT[2016/03]
French:ANTICORPS BISPÉCIFIQUES FACILEMENT ISOLÉS AVEC UN FORMAT NATIF D'IMMUNOGLOBULINE[2016/03]
Examination procedure20.07.2016Amendment by applicant (claims and/or description)
20.07.2016Examination requested  [2016/35]
08.08.2018Despatch of a communication from the examining division (Time limit: M06)
18.03.2019Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
24.05.2019Reply to a communication from the examining division
28.09.2020Date of oral proceedings
12.10.2020Minutes of oral proceedings despatched
03.11.2020Communication of intention to grant the patent
03.03.2021Fee for grant paid
03.03.2021Fee for publishing/printing paid
03.03.2021Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP10726775.9  / EP2445936
Divisional application(s)EP21160445.9  / EP3916011
Opposition(s)17.01.2022No opposition filed within time limit [2022/12]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
24.05.2019Request for further processing filed
24.05.2019Full payment received (date of receipt of payment)
Request granted
05.06.2019Decision despatched
Fees paidRenewal fee
14.08.2015Renewal fee patent year 03
14.08.2015Renewal fee patent year 04
14.08.2015Renewal fee patent year 05
14.08.2015Renewal fee patent year 06
23.06.2016Renewal fee patent year 07
22.06.2017Renewal fee patent year 08
22.06.2018Renewal fee patent year 09
21.06.2019Renewal fee patent year 10
31.03.2020Renewal fee patent year 11
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XA]US5945311  (LINDHOFER HORST [DE], et al);
 [XA]US2002051780  (LINDHOFER HORST [DE], et al);
ExaminationDE4419399
by applicantUS7183076
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.